Quick Answer
ATOSSA THERAPEUTICS, INC. reported Total Assets of $47.61 million for fiscal year 2025.
ATOSSA THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $47.61M | -37.7% |
| 2024 | $76.44M | -20.6% |
| 2023 | $96.25M | -22.1% |
| 2022 | $123.53M | -12.6% |
| 2021 | $141.26M | +229.8% |
| 2020 | $42.84M | +195.6% |
| 2019 | $14.49M | +23.6% |
| 2018 | $11.72M | +43.6% |
| 2017 | $8.16M | +97.0% |
| 2016 | $4.14M | -33.6% |
| 2015 | $6.24M | -46.9% |
| 2014 | $11.76M | -2.0% |
| 2013 | $12.01M | +75.9% |
| 2012 | $6.83M | +122.2% |
| 2011 | $3.07M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $58.01M | -27.0% | -10.1% |
| June 30, 2025 | $64.52M | -24.9% | -8.8% |
| March 31, 2025 | $70.75M | -22.3% | -7.5% |
| December 31, 2024 | $76.44M | -20.6% | -3.8% |
| September 30, 2024 | $79.48M | -21.8% | -7.4% |
| June 30, 2024 | $85.86M | -20.8% | -5.7% |
| March 31, 2024 | $91.09M | -21.6% | -5.4% |
| December 31, 2023 | $96.25M | -22.1% | -5.4% |
- ATOSSA THERAPEUTICS, INC. showed a decrease of -37.7% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, ATOSSA THERAPEUTICS, INC.’s total assets has grown by 1449.8% (from $3.07 million to $47.61 million).
- The most recent figure is from ATOSSA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: